IS6223A - Fjölbrigða salt - Google Patents

Fjölbrigða salt

Info

Publication number
IS6223A
IS6223A IS6223A IS6223A IS6223A IS 6223 A IS6223 A IS 6223A IS 6223 A IS6223 A IS 6223A IS 6223 A IS6223 A IS 6223A IS 6223 A IS6223 A IS 6223A
Authority
IS
Iceland
Prior art keywords
polymeric salt
polymeric
salt
Prior art date
Application number
IS6223A
Other languages
English (en)
Other versions
IS2162B (is
Inventor
Bentley Arthur
Arnold Howard-Field Simon
James Ogilvie Ronald
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS6223A publication Critical patent/IS6223A/is
Publication of IS2162B publication Critical patent/IS2162B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS6223A 1999-09-28 2002-01-08 Fjölbrigðasalt af lyfi gegn mígreni IS2162B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9922963.5A GB9922963D0 (en) 1999-09-28 1999-09-28 Polymorphic salt
PCT/IB2000/001305 WO2001023377A2 (en) 1999-09-28 2000-09-14 Polymorphic salt

Publications (2)

Publication Number Publication Date
IS6223A true IS6223A (is) 2002-01-08
IS2162B IS2162B (is) 2006-11-15

Family

ID=10861767

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6223A IS2162B (is) 1999-09-28 2002-01-08 Fjölbrigðasalt af lyfi gegn mígreni

Country Status (50)

Country Link
US (1) US6369094B1 (is)
EP (1) EP1233960B1 (is)
JP (1) JP3795395B2 (is)
KR (1) KR100479897B1 (is)
CN (1) CN1155594C (is)
AP (1) AP2004A (is)
AR (1) AR025779A1 (is)
AT (1) ATE246185T1 (is)
AU (1) AU779580B2 (is)
BG (1) BG65161B1 (is)
BR (1) BR0014272A (is)
CA (1) CA2379572C (is)
CO (1) CO5180567A1 (is)
CR (1) CR6561A (is)
CU (1) CU23200A3 (is)
CZ (1) CZ2002971A3 (is)
DE (1) DE60004262T2 (is)
DK (1) DK1233960T3 (is)
DZ (1) DZ3254A1 (is)
EA (1) EA004510B1 (is)
EE (1) EE200200171A (is)
EG (1) EG24143A (is)
ES (1) ES2200911T3 (is)
GB (1) GB9922963D0 (is)
GE (1) GEP20043365B (is)
GT (1) GT200000159A (is)
HK (1) HK1048628B (is)
HR (1) HRP20020270B1 (is)
HU (1) HUP0202821A3 (is)
IL (1) IL147154A (is)
IS (1) IS2162B (is)
MA (1) MA26821A1 (is)
MX (1) MXPA02003311A (is)
MY (1) MY121170A (is)
NO (1) NO321936B1 (is)
NZ (1) NZ516093A (is)
OA (1) OA12024A (is)
PA (1) PA8498901A1 (is)
PE (1) PE20010662A1 (is)
PL (1) PL354960A1 (is)
PT (1) PT1233960E (is)
SI (1) SI1233960T1 (is)
SK (1) SK3982002A3 (is)
TN (1) TNSN00187A1 (is)
TR (1) TR200200804T2 (is)
TW (1) TWI265926B (is)
UA (1) UA72272C2 (is)
WO (1) WO2001023377A2 (is)
YU (1) YU2602A (is)
ZA (1) ZA200202406B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060025387A1 (en) * 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
GB0018968D0 (en) * 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
US7132549B2 (en) 2003-05-30 2006-11-07 Pfizer Inc. Process
GB0312478D0 (en) * 2003-05-30 2003-07-09 Pfizer Ltd Improved process
EP3165220B2 (en) * 2004-12-03 2024-11-13 Merck Sharp & Dohme LLC Pharmaceutical composition containing an anti-nucleating agent
US20070149526A1 (en) * 2005-10-17 2007-06-28 Neurotherapeutics Pharma, L.L.C. Diuretic and diuretic-like compound analogs
KR100814109B1 (ko) * 2006-01-09 2008-03-14 한국생명공학연구원 로다닌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 약학적 조성물
TWI394753B (zh) * 2006-03-17 2013-05-01 Otsuka Pharma Co Ltd 新穎替妥牟拉（ｔｅｔｏｍｉｌａｓｔ）晶體
WO2010116386A2 (en) * 2009-04-08 2010-10-14 Biophore India Pharmaceuticals Pvt. Ltd. Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
AU2010313571B2 (en) 2009-10-26 2014-07-31 Merck Sharp & Dohme Llc Solid pharmaceutical compositions containing an integrase inhibitor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559246A (en) 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5545644A (en) 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
HU225055B1 (en) * 1990-10-15 2006-05-29 Pfizer Indole derivatives, their intermediates, process for production them and pharmaceutical compositions containing the compounds
US5559129A (en) 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5607951A (en) 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5578612A (en) 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5998462A (en) * 1996-12-16 1999-12-07 Allelix Biopharmaceuticals Inc. 5-alkyl indole compounds
EP0999841B1 (en) * 1997-07-03 2001-10-17 Pfizer Limited Pharmaceutical compositions containing eletriptan hemisulphate and caffeine

Also Published As

Publication number Publication date
PT1233960E (pt) 2003-11-28
SI1233960T1 (en) 2003-12-31
ZA200202406B (en) 2003-05-28
AU779580B2 (en) 2005-01-27
TR200200804T2 (tr) 2002-07-22
US6369094B1 (en) 2002-04-09
TWI265926B (en) 2006-11-11
DK1233960T3 (da) 2003-10-27
MY121170A (en) 2005-12-30
PL354960A1 (en) 2004-03-22
CU23200A3 (es) 2007-04-06
IL147154A (en) 2005-11-20
ES2200911T3 (es) 2004-03-16
GT200000159A (es) 2002-03-20
AP2004A (en) 2009-06-10
EP1233960A2 (en) 2002-08-28
PA8498901A1 (es) 2004-02-07
EG24143A (en) 2008-08-06
BG65161B1 (bg) 2007-04-30
PE20010662A1 (es) 2001-06-23
EE200200171A (et) 2003-06-16
CO5180567A1 (es) 2002-07-30
AU6721300A (en) 2001-04-30
NO321936B1 (no) 2006-07-24
HK1048628B (zh) 2004-10-21
CN1155594C (zh) 2004-06-30
AP2002002457A0 (en) 2002-06-30
KR100479897B1 (ko) 2005-03-31
YU2602A (sh) 2004-11-25
BG106240A (en) 2002-07-31
BR0014272A (pt) 2002-05-21
ATE246185T1 (de) 2003-08-15
KR20020032627A (ko) 2002-05-03
AR025779A1 (es) 2002-12-11
HUP0202821A2 (hu) 2003-01-28
HRP20020270B1 (en) 2004-04-30
IL147154A0 (en) 2002-08-14
HK1048628A1 (en) 2003-04-11
GB9922963D0 (en) 1999-12-01
EA200200302A1 (ru) 2002-10-31
MXPA02003311A (es) 2002-10-04
SK3982002A3 (en) 2003-05-02
WO2001023377A2 (en) 2001-04-05
JP2003510318A (ja) 2003-03-18
CR6561A (es) 2005-04-04
CN1364166A (zh) 2002-08-14
DE60004262D1 (de) 2003-09-04
DZ3254A1 (fr) 2001-04-05
TNSN00187A1 (fr) 2005-11-10
DE60004262T2 (de) 2004-01-22
IS2162B (is) 2006-11-15
CA2379572C (en) 2006-11-14
HUP0202821A3 (en) 2003-12-29
WO2001023377A3 (en) 2002-03-07
OA12024A (en) 2006-04-19
CZ2002971A3 (cs) 2003-04-16
CA2379572A1 (en) 2001-04-05
EA004510B1 (ru) 2004-04-29
UA72272C2 (uk) 2005-02-15
GEP20043365B (en) 2004-05-10
NO20021525D0 (no) 2002-03-26
HRP20020270A2 (en) 2003-06-30
MA26821A1 (fr) 2004-12-20
NZ516093A (en) 2005-01-28
JP3795395B2 (ja) 2006-07-12
WO2001023377A9 (en) 2002-03-28
NO20021525L (no) 2002-03-26
EP1233960B1 (en) 2003-07-30

Similar Documents

Publication Publication Date Title
DE60036160D1 (de) Elektroentionisierungsvorrichtung
DE60011764D1 (de) Werkstoffsprüfung
DE69932949D1 (de) Aufszugssteuerung
DE60002808D1 (de) Propellerrotornabe
PT1218009E (pt) Grandulos de quetiapina
DK1244625T3 (da) 4-pyridinyl-n-acyl-l-phenylalaniner
DK1190020T3 (da) Celluligninbrændstof
DE50009570D1 (de) Wechselcorrugator
DE60001894T2 (de) Busschienenverbindungsstruktur
PT1218096E (pt) Microcapsulas de libertacao variavel
DE69924240D1 (de) Ladungsträgerteilchenstrahlvorrichtung
PT1163256E (pt) Hemi-hidrato de 16-alfa-bromoepiandrosterona
PT1233960E (pt) Sal polimorfico
DE60025623D1 (de) Bohrmeisselverbinder
PT1235566E (pt) Formulacao injectavel de valnemulina
DE50012482D1 (de) Tibiamarknagel
DE60013238D1 (de) Klingenabstreifanordnung
DE60020201D1 (de) Koaxialkabelherstellungsverfahren
DE50003660D1 (de) Diacylhydrazinderivate
DE60027753D1 (de) Kompositnadel
DE19983890T1 (de) Ventiltaktgebungsjustiereinrichtung
DE69926805D1 (de) Formblaszusammensetzung
DE60000485D1 (de) Kulturgefass
DK1242386T3 (da) Nitro-sulfobenzamider
DE60037169D1 (de) Chrominanzsignalinterpolation